Introduction
The continuing increase in life span is unfortunately associated with an increased prevalence of cognitive dysfunctions, including memory loss and diminished ability to form new long-term memories. Aging-related memory impairment is a common condition characterized by mild symptoms of cognitive decline. The aged population becomes slower in processing, storing and recalling new information, and shows impairments in cognitive functioning, including memory, concentration and organization. 'I forget names so easily now' or 'I forget where I put things all the time' are common complaints of the aged. More dramatic and devastating are the cognitive and memory losses in neurodegenerative diseases, such as Alzheimer's disease (AD), in which the impairments interfere with normal life functioning. The economic impact of AD in the USA alone is estimated to be more than US$100 billion annually [1] . Thus, it is imperative to identify or develop approaches that can restore or prevent memory impairments. Furthermore, ethical debates aside, the possibility of speeding normal learning and boosting memory retention is appealing to the healthy population. Hence, identifying memory enhancers is of great importance and interest.
Numerous studies have indicated that memory can be enhanced with many types of strategy or drug that can either boost the baseline of the biological systems or modulate memory strengthening or retrieval. These drugs modulate neurotransmission, neurotransmitter receptors, neuropeptide [2-4], stress and related hormones [5, 6] and metabolism [7, 8] . The literature on this topic and the list of effective drugs is vast. Here, we focus our discussions on an ensemble of mechanisms that can be targeted to boost memories because they underlie the memory processes known as consolidation and reconsolidation. Indeed, one approach that can be employed to search for mechanisms and targets of memory enhancement is to identify and exploit the biological mechanisms by which learned information transforms into long-lasting memory. Newly learned information becomes a long-term memory through a process known as consolidation. This process converts the new labile memory trace into a stronger one that is resilient to disruption [9] . Consolidation requires an initial phase of de novo gene expression that in animal models of temporal lobe-dependent memories takes place over the first 24 h after training; its interruption results in memory loss [10, 11] . Moreover, once stable and resilient to disruption, memories can again become labile and sensitive to interference if they are reactivated by, for example, recalling the memory. Memories then regain their resilience to interference by undergoing a process known as reconsolidation [12] [13] [14] [15] . In several types of memory, reconsolidation has been found to be temporally limited. In fact, in rodents, only young memories (weeks-old), not old (months-old) ones are lost after amnesic agents are given together with memory reactivation [16] [17] [18] [19] [20] . It has been proposed that reconsolidation is a phase of lingering consolidation that in rodents can last for weeks [15, 21] . If memory is retrieved during this sensitive phase, it undergoes reconsolidation to strengthen the memory itself, indicating that an important function of the post-retrieval reconsolidation process is to promote memory strengthening and persistence [15, 22] . Thus, in principle, a strategy that potentiates either the initial consolidation or the reconsolidation phases may be successfully exploited as an effective cognitive enhancer. In agreement with this hypothesis, various gene mutations targeting the pathways known to be involved in longterm plasticity or memory formation result in memory Review
